neo-gambogic acid has been researched along with sb 203580 in 1 studies
Studies (neo-gambogic acid) | Trials (neo-gambogic acid) | Recent Studies (post-2010) (neo-gambogic acid) | Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) |
---|---|---|---|---|---|
63 | 0 | 59 | 3,489 | 4 | 1,137 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, H; Li, QL; Peng, JY; Su, JJ; Wang, M; Wang, XC; Wang, XS; Yan, FG | 1 |
1 other study(ies) available for neo-gambogic acid and sb 203580
Article | Year |
---|---|
Gambogenic acid inhibits proliferation of A549 cells through apoptosis inducing through up-regulation of the p38 MAPK cascade.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 9; Cytochromes c; Garcinia; Humans; Imidazoles; Mice; Molecular Structure; p38 Mitogen-Activated Protein Kinases; Pyridines; Terpenes; Up-Regulation; Xanthenes; Xanthones | 2011 |